Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Betamethasone 17-benzoate
1. Betamethasone 17-benzoate
2. 22298-29-9
3. Uticort
4. Benisone
5. W 5975
6. W-5975
7. Ms 1112
8. 877k0xw47a
9. Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.beta.)-
10. Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16beta)-
11. 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-benzoate
12. Euvaderm
13. Flurobate
14. Parbetan
15. Beben
16. Unii-877k0xw47a
17. Betamethasone Benzoate [usan:usp]
18. Einecs 244-897-9
19. Uticort (tn)
20. Betamethasone-17-benzoate
21. Bethamethasone 17-benzoate
22. Schembl49469
23. [(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] Benzoate
24. Betamethasone Benzoate (usp)
25. Chembl1200376
26. Dtxsid2022670
27. Chebi:135798
28. Zinc4212134
29. Betamethasone Benzoate [usan]
30. Betamethasonebenzoate(200mg)
31. Hy-u00161
32. Betamethasone Benzoate [vandf]
33. Betamethasone Benzoate [mart.]
34. Betamethasone Benzoate [usp-rs]
35. Betamethasone Benzoate [who-dd]
36. Cs-7216
37. 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-benzoate
38. Betamethasone 17-benzoate [mi]
39. Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-, 17-benzoate
40. Betamethasone Benzoate [orange Book]
41. Betamethasone Benzoate [usp Impurity]
42. D02286
43. Q27269802
44. (11.beta.,16.beta.)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione17-benzoate
45. (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl Benzoate
46. 9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl Benzoate, (11.beta.,16.beta.)-#
| Molecular Weight | 496.6 g/mol |
|---|---|
| Molecular Formula | C29H33FO6 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 496.22611693 g/mol |
| Monoisotopic Mass | 496.22611693 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 1030 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Betamethasone Benzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betamethasone Benzoate, including repackagers and relabelers. The FDA regulates Betamethasone Benzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betamethasone Benzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Betamethasone Benzoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Betamethasone Benzoate supplier is an individual or a company that provides Betamethasone Benzoate active pharmaceutical ingredient (API) or Betamethasone Benzoate finished formulations upon request. The Betamethasone Benzoate suppliers may include Betamethasone Benzoate API manufacturers, exporters, distributors and traders.
click here to find a list of Betamethasone Benzoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Betamethasone Benzoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Betamethasone Benzoate active pharmaceutical ingredient (API) in detail. Different forms of Betamethasone Benzoate DMFs exist exist since differing nations have different regulations, such as Betamethasone Benzoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Betamethasone Benzoate DMF submitted to regulatory agencies in the US is known as a USDMF. Betamethasone Benzoate USDMF includes data on Betamethasone Benzoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Betamethasone Benzoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Betamethasone Benzoate suppliers with USDMF on PharmaCompass.
Betamethasone Benzoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betamethasone Benzoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Betamethasone Benzoate GMP manufacturer or Betamethasone Benzoate GMP API supplier for your needs.
A Betamethasone Benzoate CoA (Certificate of Analysis) is a formal document that attests to Betamethasone Benzoate's compliance with Betamethasone Benzoate specifications and serves as a tool for batch-level quality control.
Betamethasone Benzoate CoA mostly includes findings from lab analyses of a specific batch. For each Betamethasone Benzoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betamethasone Benzoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Betamethasone Benzoate EP), Betamethasone Benzoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betamethasone Benzoate USP).
LOOKING FOR A SUPPLIER?
